There are 2949 resources available
1350P - Real-world treatment outcomes with brigatinib in patients with pretreated ALK+ metastatic non-small cell lung cancer (mNSCLC)
Presenter: Sanjay Popat
Session: E-Poster Display
Resources:
Abstract
1351P - The impact of BRCA mutation status on NSCLC disease course and response to therapy
Presenter: Roi Tschernichovsky
Session: E-Poster Display
Resources:
Abstract
1352P - Circulating tumour (ct) DNA next generation sequencing (NGS) in advanced non-small cell lung cancer (mNSCLC): A UK single institution experience
Presenter: Wanyuan Cui
Session: E-Poster Display
Resources:
Abstract
1353P - Clinical utility of circulating tumour (ct) DNA next generation sequencing (NGS) for target identification in diagnostic and acquired resistance settings in metastatic NSCLC (mNSCLC): Single centre experience
Presenter: Nadza Tokaca
Session: E-Poster Display
Resources:
Abstract
1354P - Detection of EGFR T790M in EGFR activating mutation-positive advanced non-small cell lung cancer (NSCLC): Comparison between two assays on circulating tumour (ct)DNA
Presenter: Sandrine Charpentier
Session: E-Poster Display
Resources:
Abstract
1355P - Value of rebiopsy in advanced epidermal growth factor receptor mutated non-small cell lung cancer: Real-world data
Presenter: Rita Conde
Session: E-Poster Display
Resources:
Abstract
1356P - Disease monitoring and TKI resistance mutations of EGFR mutation-positive NSCLC patients via circulating tumour DNA
Presenter: Christine Ju
Session: E-Poster Display
Resources:
Abstract
1357P - Outcomes of treated patients with EGFR-mutated advanced or metastatic non-small cell lung cancer harboring exon 19 deletions or L858R substitution (Exon 21) mutations: A systematic literature review
Presenter: Katherine Winfree
Session: E-Poster Display
Resources:
Abstract
1358P - Efficacy and toxicity of combined inhibition of EGFR and VEGFR in advanced non-small cell lung cancer patients harboring activating EGFR mutations: A systematic review and meta-analysis
Presenter: Jasna Deluce
Session: E-Poster Display
Resources:
Abstract
1359P - Clinical characteristics of advanced NSCLC patients with phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) mutations
Presenter: Sameh Daher
Session: E-Poster Display
Resources:
Abstract